{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:59:40Z","timestamp":1763665180476,"version":"3.37.3"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s11095-023-03550-9","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T21:01:40Z","timestamp":1686603700000},"page":"2533-2540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proton-Coupled Oligopeptide Transport (Slc15) in the Brain: Past and Future Research"],"prefix":"10.1007","volume":"40","author":[{"given":"Jianming","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6441-5334","authenticated-orcid":false,"given":"Richard F.","family":"Keep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"issue":"2-3","key":"3550_CR1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.mam.2012.11.003","volume":"34","author":"DE Smith","year":"2013","unstructured":"Smith DE, Clemencon B, Hediger MA. Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol Asp Med. 2013;34(2-3):323\u201336.","journal-title":"Mol Asp Med."},{"issue":"1-2","key":"3550_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gene.2010.10.011","volume":"478","author":"S Sreedharan","year":"2011","unstructured":"Sreedharan S, Stephansson O, Schi\u00f6th HB, Fredriksson R. Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters. Gene. 2011;478(1-2):11\u20138.","journal-title":"Gene."},{"issue":"3","key":"3550_CR3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00360-016-1044-7","volume":"187","author":"T Verri","year":"2017","unstructured":"Verri T, Barca A, Pisani P, Piccinni B, Storelli C, Romano A. Di- and tripeptide transport in vertebrates: the contribution of teleost fish models. J Comp Physiol B. 2017;187(3):395\u2013462.","journal-title":"J Comp Physiol B."},{"issue":"6471","key":"3550_CR4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/368563a0","volume":"368","author":"YJ Fei","year":"1994","unstructured":"Fei YJ, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF, Singh SK, Boron WF, Hediger MA. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature. 1994;368(6471):563\u20136.","journal-title":"Nature."},{"issue":"2","key":"3550_CR5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0005-2736(95)80036-F","volume":"1235","author":"W Liu","year":"1995","unstructured":"Liu W, Liang R, Ramamoorthy S, Fei YJ, Ganapathy ME, Hediger MA, Ganapathy V, Leibach FH. Molecular cloning of PEPT 2, a new member of the H+\/peptide cotransporter family, from human kidney. Biochim Biophys Acta. 1995;1235(2):461\u20136.","journal-title":"Biochim Biophys Acta."},{"issue":"4","key":"3550_CR6","doi-asserted-by":"crossref","first-page":"C967","DOI":"10.1152\/ajpcell.1998.275.4.C967","volume":"275","author":"H Wang","year":"1998","unstructured":"Wang H, Fei YJ, Ganapathy V, Leibach FH. Electrophysiological characteristics of the proton-coupled peptide transporter PEPT2 cloned from rat brain. Am J Physiol. 1998;275(4):C967\u201375.","journal-title":"Am J Physiol."},{"issue":"15","key":"3550_CR7","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1074\/jbc.272.15.10205","volume":"272","author":"T Yamashita","year":"1997","unstructured":"Yamashita T, Shimada S, Guo W, Sato K, Kohmura E, Hayakawa T, Takagi T, Tohyama M. Cloning and functional expression of a brain peptide\/histidine transporter. J Biol Chem. 1997;272(15):10205\u201311.","journal-title":"J Biol Chem."},{"issue":"6","key":"3550_CR8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jnc.12687","volume":"129","author":"Y Hu","year":"2014","unstructured":"Hu Y, Xie Y, Keep RF, Smith DE. Divergent developmental expression and function of the proton-coupled oligopeptide transporters PepT2 and PhT1 in regional brain slices of mouse and rat. J Neurochem. 2014;129(6):955\u201365.","journal-title":"J Neurochem."},{"issue":"Pt 1","key":"3550_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/bj3560053","volume":"356","author":"K Sakata","year":"2001","unstructured":"Sakata K, Yamashita T, Maeda M, Moriyama Y, Shimada S, Tohyama M. Cloning of a lymphatic peptide\/histidine transporter. Biochem J. 2001;356(Pt 1):53\u201360.","journal-title":"Biochem J."},{"issue":"4","key":"3550_CR10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1021\/mp049944b","volume":"1","author":"H Shen","year":"2004","unstructured":"Shen H, Smith DE, Keep RF, Brosius FC 3rd. Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol Pharm. 2004;1(4):248\u201356.","journal-title":"Mol Pharm."},{"issue":"7","key":"3550_CR11","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s11095-022-03275-1","volume":"39","author":"H Takeuchi","year":"2022","unstructured":"Takeuchi H, Suzuki M, Goto R, Tezuka K, Fuchs H, Ishiguro N, Terasaki T, Braun C, Uchida Y. Regional differences in the absolute abundance of transporters, receptors and tight junction molecules at the blood-arachnoid barrier and blood-spinal cord barrier among cervical, thoracic and lumbar spines in dogs. Pharm Res. 2022;39(7):1393\u2013413.","journal-title":"Pharm Res."},{"issue":"2","key":"3550_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1124\/dmd.119.089516","volume":"48","author":"Y Uchida","year":"2020","unstructured":"Uchida Y, Goto R, Takeuchi H, Luczak M, Usui T, Tachikawa M, Terasaki T. Abundant expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT transporters in blood-arachnoid barrier of pig and polarized localizations at CSF- and blood-facing plasma membranes. Drug Metabolism Disposition. 2020;48(2):135\u201345.","journal-title":"Drug Metabolism Disposition."},{"issue":"7693","key":"3550_CR13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature25739","volume":"554","author":"M Vanlandewijck","year":"2018","unstructured":"Vanlandewijck M, He L, Mae MA, Andrae J, Ando K, Del Gaudio F, Nahar K, Lebouvier T, Lavina B, Gouveia L, Sun Y, Raschperger E, Rasanen M, Zarb Y, Mochizuki N, Keller A, Lendahl U, Betsholtz C. A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018;554(7693):475\u201380.","journal-title":"Nature."},{"issue":"3","key":"3550_CR14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF02354286","volume":"23","author":"AR Kugler","year":"1995","unstructured":"Kugler AR, Olson SC, Smith DE. Disposition of quinapril and quinaprilat in the isolated perfused rat kidney. J Pharmacokinet Biopharm. 1995;23(3):287\u2013305.","journal-title":"J Pharmacokinet Biopharm."},{"issue":"2","key":"3550_CR15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.47.2.689-696.2003","volume":"47","author":"CS Lepsy","year":"2003","unstructured":"Lepsy CS, Guttendorf RJ, Kugler AR, Smith DE. Effects of organic anion, organic cation, and dipeptide transport inhibitors on cefdinir in the isolated perfused rat kidney. Antimicrob Agents Chemother. 2003;47(2):689\u201396.","journal-title":"Antimicrob Agents Chemother."},{"issue":"11","key":"3550_CR16","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.35.11.2395","volume":"35","author":"CA Rodriguez","year":"1991","unstructured":"Rodriguez CA, Smith DE. Influence of the unbound concentration of cefonicid on its renal elimination in isolated perfused rat kidneys. Antimicrob Agents Chemother. 1991;35(11):2395\u2013400.","journal-title":"Antimicrob Agents Chemother."},{"issue":"5","key":"3550_CR17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/scientificamerican1189-68","volume":"261","author":"R Spector","year":"1989","unstructured":"Spector R, Johanson CE. The mammalian choroid plexus. Sci Am. 1989;261(5):68\u201374.","journal-title":"Sci Am."},{"issue":"3","key":"3550_CR18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00401-018-1807-1","volume":"135","author":"JF Ghersi-Egea","year":"2018","unstructured":"Ghersi-Egea JF, Strazielle N, Catala M, Silva-Vargas V, Doetsch F, Engelhardt B. Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease. Acta Neuropathol. 2018;135(3):337\u201361.","journal-title":"Acta Neuropathol."},{"issue":"1","key":"3550_CR19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1471-4159.2000.0750321.x","volume":"75","author":"A Novotny","year":"2000","unstructured":"Novotny A, Xiang J, Stummer W, Teuscher NS, Smith DE, Keep RF. Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus. J Neurochem. 2000;75(1):321\u20138.","journal-title":"J Neurochem."},{"issue":"2","key":"3550_CR20","first-page":"494","volume":"294","author":"NS Teuscher","year":"2000","unstructured":"Teuscher NS, Novotny A, Keep RF, Smith DE. Functional evidence for presence of PEPT2 in rat choroid plexus: studies with glycylsarcosine. J Pharm Exp Ther. 2000;294(2):494\u20139.","journal-title":"J Pharm Exp Ther."},{"issue":"3","key":"3550_CR21","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1124\/jpet.301.3.820","volume":"301","author":"C Shu","year":"2002","unstructured":"Shu C, Shen H, Teuscher NS, Lorenzi PJ, Keep RF, Smith DE. Role of PEPT2 in peptide\/mimetic trafficking at the blood-cerebrospinal fluid barrier: studies in rat choroid plexus epithelial cells in primary culture. J Pharm Exp Ther. 2002;301(3):820\u20139.","journal-title":"J Pharm Exp Ther."},{"issue":"8","key":"3550_CR22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s11095-005-5261-0","volume":"22","author":"Y Hu","year":"2005","unstructured":"Hu Y, Ocheltree SM, Xiang J, Keep RF, Smith DE. Glycyl-L-glutamine disposition in rat choroid plexus epithelial cells in primary culture: role of PEPT2. Pharm Res. 2005;22(8):1281\u20136.","journal-title":"Pharm Res."},{"issue":"9","key":"3550_CR23","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1023\/B:PHAM.0000041465.89254.05","volume":"21","author":"SM Ocheltree","year":"2004","unstructured":"Ocheltree SM, Shen H, Hu Y, Xiang J, Keep RF, Smith DE. Role of PEPT2 in the choroid plexus uptake of glycylsarcosine and 5-aminolevulinic acid: studies in wild-type and null mice. Pharm Res. 2004;21(9):1680\u20135.","journal-title":"Pharm Res."},{"issue":"2","key":"3550_CR24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1124\/jpet.103.060400","volume":"308","author":"SM Ocheltree","year":"2004","unstructured":"Ocheltree SM, Shen H, Hu Y, Xiang J, Keep RF, Smith DE. Mechanisms of cefadroxil uptake in the choroid plexus: studies in wild-type and PEPT2 knockout mice. J Pharm Exp Ther. 2004;308(2):462\u20137.","journal-title":"J Pharm Exp Ther."},{"issue":"3","key":"3550_CR25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1124\/jpet.105.090654","volume":"315","author":"H Shen","year":"2005","unstructured":"Shen H, Keep RF, Hu Y, Smith DE. PEPT2 (Slc15a2)-mediated unidirectional transport of cefadroxil from cerebrospinal fluid into choroid plexus. J Pharm Exp Ther. 2005;315(3):1101\u20138.","journal-title":"J Pharm Exp Ther."},{"issue":"7","key":"3550_CR26","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1074\/jbc.M207397200","volume":"278","author":"H Shen","year":"2003","unstructured":"Shen H, Smith DE, Keep RF, Xiang J, Brosius FC 3rd. Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus. J Biol Chem. 2003;278(7):4786\u201391.","journal-title":"J Biol Chem."},{"issue":"6","key":"3550_CR27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1011088413043","volume":"18","author":"NS Teuscher","year":"2001","unstructured":"Teuscher NS, Keep RF, Smith DE. PEPT2-mediated uptake of neuropeptides in rat choroid plexus. Pharm Res. 2001;18(6):807\u201313.","journal-title":"Pharm Res."},{"issue":"2","key":"3550_CR28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1471-4159.2004.02333.x","volume":"89","author":"NS Teuscher","year":"2004","unstructured":"Teuscher NS, Shen H, Shu C, Xiang J, Keep RF, Smith DE. Carnosine uptake in rat choroid plexus primary cell cultures and choroid plexus whole tissue from PEPT2 null mice. J Neurochem. 2004;89(2):375\u201382.","journal-title":"J Neurochem."},{"issue":"1","key":"3550_CR29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/jpet.105.089359","volume":"315","author":"SM Ocheltree","year":"2005","unstructured":"Ocheltree SM, Shen H, Hu Y, Keep RF, Smith DE. Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice. J Pharm Exp Ther. 2005;315(1):240\u20137.","journal-title":"J Pharm Exp Ther."},{"issue":"7","key":"3550_CR30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1124\/dmd.107.015263","volume":"35","author":"H Shen","year":"2007","unstructured":"Shen H, Ocheltree SM, Hu Y, Keep RF, Smith DE. Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab Dispos. 2007;35(7):1209\u201316.","journal-title":"Drug Metab Dispos."},{"issue":"4","key":"3550_CR31","first-page":"R986","volume":"296","author":"MA Kamal","year":"2009","unstructured":"Kamal MA, Jiang H, Hu Y, Keep RF, Smith DE. Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice. Am J Phys Regul Integr Comp Phys. 2009;296(4):R986\u201391.","journal-title":"Am J Phys Regul Integr Comp Phys."},{"key":"3550_CR32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bcp.2017.02.005","volume":"131","author":"X Chen","year":"2017","unstructured":"Chen X, Keep RF, Liang Y, Zhu HJ, Hammarlund-Udenaes M, Hu Y, Smith DE. Influence of peptide transporter 2 (PEPT2) on the distribution of cefadroxil in mouse brain: a microdialysis study. Biochem Pharmacol. 2017;131:89\u201397.","journal-title":"Biochem Pharmacol."},{"issue":"1","key":"3550_CR33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/jcbfm.2010.84","volume":"31","author":"DE Smith","year":"2011","unstructured":"Smith DE, Hu Y, Shen H, Nagaraja TN, Fenstermacher JD, Keep RF. Distribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null mice. J Cereb Blood Flow Metab. 2011;31(1):250\u201361.","journal-title":"J Cereb Blood Flow Metab."},{"issue":"5","key":"3550_CR34","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1471-4159.2007.04905.x","volume":"103","author":"Y Hu","year":"2007","unstructured":"Hu Y, Shen H, Keep RF, Smith DE. Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity. J Neurochem. 2007;103(5):2058\u201365.","journal-title":"J Neurochem."},{"issue":"5","key":"3550_CR35","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1471-4159.2009.06090.x","volume":"109","author":"H Jiang","year":"2009","unstructured":"Jiang H, Hu Y, Keep RF, Smith DE. Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice. J Neurochem. 2009;109(5):1536\u201343.","journal-title":"J Neurochem."},{"issue":"3","key":"3550_CR36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neulet.2005.11.037","volume":"396","author":"J Xiang","year":"2006","unstructured":"Xiang J, Chiang PP, Hu Y, Smith DE, Keep RF. Role of PEPT2 in glycylsarcosine transport in astrocyte and glioma cultures. Neurosci Lett. 2006;396(3):225\u20139.","journal-title":"Neurosci Lett."},{"issue":"1","key":"3550_CR37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2006.09.013","volume":"1122","author":"J Xiang","year":"2006","unstructured":"Xiang J, Hu Y, Smith DE, Keep RF. PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes. Brain Res. 2006;1122(1):18\u201323.","journal-title":"Brain Res."},{"key":"3550_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2010.05.094","volume":"1347","author":"J Xiang","year":"2010","unstructured":"Xiang J, Jiang H, Hu Y, Smith DE, Keep RF. Kyotorphin transport and metabolism in rat and mouse neonatal astrocytes. Brain Res. 2010;1347:11\u20138.","journal-title":"Brain Res."},{"issue":"1","key":"3550_CR39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2003.10.049","volume":"997","author":"T Fujita","year":"2004","unstructured":"Fujita T, Kishida T, Wada M, Okada N, Yamamoto A, Leibach FH, Ganapathy V. Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H+\/peptide transporter PEPT2. Brain Res. 2004;997(1):52\u201361.","journal-title":"Brain Res."},{"issue":"8","key":"3550_CR40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00726-021-03094-5","volume":"54","author":"AV Lopachev","year":"2022","unstructured":"Lopachev AV, Abaimov DA, Filimonov IS, Kulichenkova KN, Fedorova TN. An assessment of the transport mechanism and intraneuronal stability of L-carnosine. Amino Acids. 2022;54(8):1115\u201322.","journal-title":"Amino Acids."},{"issue":"5","key":"3550_CR41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s004290050242","volume":"199","author":"UV Berger","year":"1999","unstructured":"Berger UV, Hediger MA. Distribution of peptide transporter PEPT2 mRNA in the rat nervous system. Anat Embryol. 1999;199(5):439\u201349.","journal-title":"Anat Embryol."},{"key":"3550_CR42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bcp.2016.11.012","volume":"124","author":"XX Wang","year":"2017","unstructured":"Wang XX, Hu Y, Keep RF, Toyama-Sorimachi N, Smith DE. A novel role for PHT1 in the disposition of l-histidine in brain: in vitro slice and in vivo pharmacokinetic studies in wildtype and Pht1 null mice. Biochem Pharmacol. 2017;124:94\u2013102.","journal-title":"Biochem Pharmacol."},{"issue":"12","key":"3550_CR43","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.addr.2004.07.008","volume":"56","author":"DE Smith","year":"2004","unstructured":"Smith DE, Johanson CE, Keep RF. Peptide and peptide analog transport systems at the blood-CSF barrier. Adv Drug Deliv Rev. 2004;56(12):1765\u201391.","journal-title":"Adv Drug Deliv Rev."},{"issue":"2","key":"3550_CR44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/jnc.15599","volume":"161","author":"Y Uchida","year":"2022","unstructured":"Uchida Y, Takeuchi H, Goto R, Braun C, Fuchs H, Ishiguro N, Takao M, Tano M, Terasaki T. A human blood-arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: comparison with dog and pig in absolute abundance. J Neurochem. 2022;161(2):187\u2013208.","journal-title":"J Neurochem."},{"issue":"5","key":"3550_CR45","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2011.01.041","volume":"140","author":"S Sasawatari","year":"2011","unstructured":"Sasawatari S, Okamura T, Kasumi E, Tanaka-Furuyama K, Yanobu-Takanashi R, Shirasawa S, Kato N, Toyama-Sorimachi N. The solute carrier family 15A4 regulates TLR9 and NOD1 functions in the innate immune system and promotes colitis in mice. Gastroenterol. 2011;140(5):1513\u201325.","journal-title":"Gastroenterol."},{"issue":"7","key":"3550_CR46","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41419-018-0809-1","volume":"9","author":"F Song","year":"2018","unstructured":"Song F, Yi Y, Li C, Hu Y, Wang J, Smith DE, Jiang H. Regulation and biological role of the peptide\/histidine transporter SLC15A3 in toll-like receptor-mediated inflammatory responses in macrophage. Cell Death Dis. 2018;9(7):770.","journal-title":"Cell Death Dis."},{"issue":"4","key":"3550_CR47","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1021\/mp300700p","volume":"10","author":"D Sun","year":"2013","unstructured":"Sun D, Wang Y, Tan F, Fang D, Hu Y, Smith DE, Jiang H. Functional and molecular expression of the proton-coupled oligopeptide transporters in spleen and macrophages from mouse and human. Mol Pharm. 2013;10(4):1409\u201316.","journal-title":"Mol Pharm."},{"issue":"6","key":"3550_CR48","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1021\/mp500014r","volume":"11","author":"Y Wang","year":"2014","unstructured":"Wang Y, Sun D, Song F, Hu Y, Smith DE, Jiang H. Expression and regulation of the proton-coupled oligopeptide transporter PhT2 by LPS in macrophages and mouse spleen. Mol Pharm. 2014;11(6):1880\u20138.","journal-title":"Mol Pharm."},{"issue":"2","key":"3550_CR49","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4049\/jimmunol.1800210","volume":"201","author":"Y Hu","year":"2018","unstructured":"Hu Y, Song F, Jiang H, Nu\u00f1ez G, Smith DE. SLC15A2 and SLC15A4 mediate the transport of bacterially derived Di\/tripeptides to enhance the nucleotide-binding oligomerization domain-dependent immune response in mouse bone marrow-derived macrophages. J Immunol. 2018;201(2):652\u201362.","journal-title":"J Immunol."},{"issue":"6","key":"3550_CR50","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41593-019-0393-4","volume":"22","author":"H Van Hove","year":"2019","unstructured":"Van Hove H, Martens L, Scheyltjens I, De Vlaminck K, Pombo Antunes AR, De Prijck S, Vandamme N, De Schepper S, Van Isterdael G, Scott CL, Aerts J, Berx G, Boeckxstaens GE, Vandenbroucke RE, Vereecke L, Moechars D, Guilliams M, Van Ginderachter JA, Saeys Y, Movahedi K. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat Neurosci. 2019;22(6):1021\u201335.","journal-title":"Nat Neurosci."},{"issue":"1","key":"3550_CR51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1098-1136(19990101)25:1<10::AID-GLIA2>3.0.CO;2-Y","volume":"25","author":"ST Dieck","year":"1999","unstructured":"Dieck ST, Heuer H, Ehrchen J, Otto C, Bauer K. The peptide transporter PepT2 is expressed in rat brain and mediates the accumulation of the fluorescent dipeptide derivative beta-ala-Lys-Nepsilon-AMCA in astrocytes. GLIA. 1999;25(1):10\u201320.","journal-title":"GLIA."},{"issue":"1","key":"3550_CR52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2005.02.064","volume":"1044","author":"M Wada","year":"2005","unstructured":"Wada M, Miyakawa S, Shimada A, Okada N, Yamamoto A, Fujita T. Functional linkage of H+\/peptide transporter PEPT2 and Na+\/H+ exchanger in primary cultures of astrocytes from mouse cerebral cortex. Brain Res. 2005;1044(1):33\u201341.","journal-title":"Brain Res."},{"issue":"3","key":"3550_CR53","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C, Galea E, Lakatos A, O'Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhauser C, Volterra A, Carmignoto G, Agarwal A, Allen NJ, Araque A, Barbeito L, Barzilai A, Bergles DE, Bonvento G, Butt AM, Chen WT, Cohen-Salmon M, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312\u201325.","journal-title":"Nat Neurosci."},{"issue":"18","key":"3550_CR54","first-page":"14","volume":"11","author":"C Wang","year":"2022","unstructured":"Wang C, Chu C, Ji X, Luo G, Xu C, He H, Yao J, Wu J, Hu J, Jin Y. Biology of peptide transporter 2 in mammals: new insights into its function, structure and regulation. Cells. 2022;11(18):14.","journal-title":"Cells."},{"issue":"2","key":"3550_CR55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.ki.5001522","volume":"70","author":"R Noshiro","year":"2006","unstructured":"Noshiro R, Anzai N, Sakata T, Miyazaki H, Terada T, Shin HJ, He X, Miura D, Inui K, Kanai Y, Endou H. The PDZ domain protein PDZK1 interacts with human peptide transporter PEPT2 and enhances its transport activity. Kidney Int. 2006;70(2):275\u201382.","journal-title":"Kidney Int."},{"issue":"7","key":"3550_CR56","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1242\/jcs.259450","volume":"135","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Tu H, Hao Y, Li D, Yang Y, Yuan Y, Guo Z, Li L, Wang H, Cai H. Oligopeptide transporter Slc15A modulates macropinocytosis in Dictyostelium by maintaining intracellular nutrient status. J Cell Sci. 2022;135(7):01.","journal-title":"J Cell Sci."},{"issue":"3","key":"3550_CR57","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1073\/pnas.1813715116","volume":"116","author":"GS Minhas","year":"2019","unstructured":"Minhas GS, Newstead S. Structural basis for prodrug recognition by the SLC15 family of proton-coupled peptide transporters. Proc Natl Acad Sci U S A. 2019;116(3):804\u20139.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"3550_CR58","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1021\/jacs.8b11343","volume":"141","author":"Y Ural-Blimke","year":"2019","unstructured":"Ural-Blimke Y, Flayhan A, Strauss J, Rantos V, Bartels K, Nielsen R, Pardon E, Steyaert J, Kosinski J, Quistgaard EM, Low C. Structure of prototypic peptide transporter DtpA from E. coli in complex with Valganciclovir provides insights into drug binding of human PepT1. J Am Chem Soc. 2019;141(6):2404\u201312.","journal-title":"J Am Chem Soc."},{"issue":"2","key":"3550_CR59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/BST20180302","volume":"48","author":"GS Minhas","year":"2020","unstructured":"Minhas GS, Newstead S. Recent advances in understanding prodrug transport through the SLC15 family of proton-coupled transporters. Biochem Soc Trans. 2020;48(2):337\u201346.","journal-title":"Biochem Soc Trans."},{"issue":"35","key":"3550_CR60","doi-asserted-by":"crossref","first-page":"08","DOI":"10.1126\/sciadv.abh3355","volume":"7","author":"JL Parker","year":"2021","unstructured":"Parker JL, Deme JC, Wu Z, Kuteyi G, Huo J, Owens RJ, Biggin PC, Lea SM, Newstead S. Cryo-EM structure of PepT2 reveals structural basis for proton-coupled peptide and prodrug transport in mammals. Sci Adv. 2021;7(35):08.","journal-title":"Sci Adv."},{"issue":"2","key":"3550_CR61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.116.073320","volume":"45","author":"F Song","year":"2017","unstructured":"Song F, Hu Y, Jiang H, Smith DE. Species differences in human and rodent PEPT2-mediated transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants. Drug Metab Dispos. 2017;45(2):130\u20136.","journal-title":"Drug Metab Dispos."},{"issue":"10","key":"3550_CR62","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1021\/mp500497p","volume":"11","author":"Y Hu","year":"2014","unstructured":"Hu Y, Xie Y, Wang Y, Chen X, Smith DE. Development and characterization of a novel mouse line humanized for the intestinal peptide transporter PEPT1. Mol Pharm. 2014;11(10):3737\u201346.","journal-title":"Mol Pharm."},{"issue":"6","key":"3550_CR63","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jnc.13147","volume":"134","author":"Y Uchida","year":"2015","unstructured":"Uchida Y, Zhang Z, Tachikawa M, Terasaki T. Quantitative targeted absolute proteomics of rat blood-cerebrospinal fluid barrier transporters: comparison with a human specimen. J Neurochem. 2015;134(6):1104\u201315.","journal-title":"J Neurochem."},{"issue":"3","key":"3550_CR64","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/acs.molpharmaceut.7b00852","volume":"15","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Tachikawa M, Uchida Y, Terasaki T. Drug clearance from cerebrospinal fluid mediated by organic anion transporters 1 (Slc22a6) and 3 (Slc22a8) at arachnoid membrane of rats. Mol Pharm. 2018;15(3):911\u201322.","journal-title":"Mol Pharm."},{"key":"3550_CR65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2020.06.008","volume":"490","author":"A Casas","year":"2020","unstructured":"Casas A. Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: a review. Cancer Lett. 2020;490:165\u201373.","journal-title":"Cancer Lett."},{"issue":"5","key":"3550_CR66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, Group AL-GS. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392\u2013401.","journal-title":"Lancet Oncol."},{"issue":"8","key":"3550_CR67","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41416-019-0516-4","volume":"121","author":"K McNicholas","year":"2019","unstructured":"McNicholas K, MacGregor MN, Gleadle JM. In order for the light to shine so brightly, the darkness must be present-why do cancers fluoresce with 5-aminolaevulinic acid? Br J Cancer. 2019;121(8):631\u20139.","journal-title":"Br J Cancer."},{"doi-asserted-by":"crossref","unstructured":"Harada Y, Murayama Y, Takamatsu T, Otsuji E, Tanaka H. 5-Aminolevulinic acid-induced Protoporphyrin IX fluorescence imaging for tumor detection: recent advances and challenges. Int J Mol Sci. 2022;23(12):6478.","key":"3550_CR68","DOI":"10.3390\/ijms23126478"},{"issue":"12","key":"3550_CR69","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1172\/JCI1909","volume":"101","author":"F Doring","year":"1998","unstructured":"Doring F, Walter J, Will J, Focking M, Boll M, Amasheh S, Clauss W, Daniel H. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J Clin Investig. 1998;101(12):2761\u20137.","journal-title":"J Clin Investig."},{"issue":"2","key":"3550_CR70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11060-019-03158-3","volume":"143","author":"C Hou","year":"2019","unstructured":"Hou C, Yamaguchi S, Ishi Y, Terasaka S, Kobayashi H, Motegi H, Hatanaka KC, Houkin K. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II\/III gliomas. J Neuro-Oncol. 2019;143(2):197\u2013206.","journal-title":"J Neuro-Oncol."},{"issue":"4","key":"3550_CR71","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2133\/dmpk.23.236","volume":"23","author":"MA Kamal","year":"2008","unstructured":"Kamal MA, Keep RF, Smith DE. Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity. Drug Metab Pharm. 2008;23(4):236\u201342.","journal-title":"Drug Metab Pharm."},{"issue":"3","key":"3550_CR72","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1124\/jpet.104.073098","volume":"311","author":"J Pinsonneault","year":"2004","unstructured":"Pinsonneault J, Nielsen CU, Sadee W. Genetic variants of the human H+\/dipeptide transporter PEPT2: analysis of haplotype functions. J Pharm Exp Ther. 2004;311(3):1088\u201396.","journal-title":"J Pharm Exp Ther."},{"issue":"6","key":"3550_CR73","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.2016080918","volume":"28","author":"D Tchernitchko","year":"2017","unstructured":"Tchernitchko D, Tavernier Q, Lamoril J, Schmitt C, Talbi N, Lyoumi S, Robreau AM, Karim Z, Gouya L, Thervet E, Karras A, Puy H, Pallet N. A variant of peptide transporter 2 predicts the severity of Porphyria-associated kidney disease. J Am Soc Nephrol. 2017;28(6):1924\u201332.","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"3550_CR74","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s00415-023-11586-5","volume":"270","author":"E Pischik","year":"2023","unstructured":"Pischik E, Baumann K, Karpenko A, Kauppinen R. Pathogenesis of acute encephalopathy in acute hepatic porphyria. J Neurol. 2023;270(5):2613\u201330.","journal-title":"J Neurol."},{"key":"3550_CR75","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ntt.2014.12.001","volume":"47","author":"C Sobin","year":"2015","unstructured":"Sobin C, Flores-Montoya MG, Gutierrez M, Parisi N, Schaub T. delta-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 (ALAD2) and peptide transporter 2 2 haplotype (hPEPT2 2) differently influence neurobehavior in low-level lead exposed children. Neurotoxicol Teratol. 2015;47:137\u201345.","journal-title":"Neurotoxicol Teratol."},{"issue":"4","key":"3550_CR76","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1471-4159.1983.tb09049.x","volume":"41","author":"U Tossman","year":"1983","unstructured":"Tossman U, Eriksson S, Delin A, Hagenfeldt L, Law D, Ungerstedt U. Brain amino acids measured by intracerebral dialysis in portacaval shunted rats. J Neurochem. 1983;41(4):1046\u201351.","journal-title":"J Neurochem."},{"issue":"4","key":"3550_CR77","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jnr.490040407","volume":"4","author":"G Zanchin","year":"1979","unstructured":"Zanchin G, Rigotti P, Dussini N, Vassanelli P, Battistin L. Cerebral amino acid levels and uptake in rats after portocaval anastomosis: II. Regional studies in vivo. J Neurosci Res. 1979;4(4):301\u201310.","journal-title":"J Neurosci Res."},{"key":"3550_CR78","first-page":"95","volume":"14","author":"M Weiser","year":"1978","unstructured":"Weiser M, Riederer P, Kleinberger G. Human cerebral free amino acids in hepatic coma. J Neural Transm Suppl. 1978;14:95\u2013102.","journal-title":"J Neural Transm Suppl."},{"issue":"10","key":"3550_CR79","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0961203310367918","volume":"19","author":"CF He","year":"2010","unstructured":"He CF, Liu YS, Cheng YL, Gao JP, Pan TM, Han JW, Quan C, Sun LD, Zheng HF, Zuo XB, Xu SX, Sheng YJ, Yao S, Hu WL, Li Y, Yu ZY, Yin XY, Zhang XJ, Cui Y, Yang S. TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus. 2010;19(10):1181\u20136.","journal-title":"Lupus."},{"issue":"9","key":"3550_CR80","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ejhg.2012.277","volume":"21","author":"C Wang","year":"2013","unstructured":"Wang C, Ahlford A, J\u00e4rvinen TM, Nordmark G, Eloranta ML, Gunnarsson I, Svenungsson E, Padyukov L, Sturfelt G, J\u00f6nsen A, Bengtsson AA, Truedsson L, Eriksson C, Rantap\u00e4\u00e4-Dahlqvist S, Sj\u00f6wall C, Julkunen H, Criswell LA, Graham RR, Behrens TW, et al. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur J Hum Genet. 2013;21(9):994\u20139.","journal-title":"Eur J Hum Genet."},{"issue":"8","key":"3550_CR81","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/gtmb.2015.0289","volume":"20","author":"M Zhang","year":"2016","unstructured":"Zhang M, Chen F, Zhang D, Zhai Z, Hao F. Association study between SLC15A4 polymorphisms and haplotypes and systemic lupus erythematosus in a Han Chinese population. Genet Test Mol Biomarker. 2016;20(8):451\u20138.","journal-title":"Genet Test Mol Biomarker."},{"issue":"4","key":"3550_CR82","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00296-013-2864-3","volume":"34","author":"XB Zuo","year":"2014","unstructured":"Zuo XB, Sheng YJ, Hu SJ, Gao JP, Li Y, Tang HY, Tang XF, Cheng H, Yin XY, Wen LL, Sun LD, Yang S, Cui Y, Zhang XJ. Variants in TNFSF4, TNFAIP3, TNIP1, BLK, SLC15A4 and UBE2L3 interact to confer risk of systemic lupus erythematosus in Chinese population. Rheumatol Int. 2014;34(4):459\u201364.","journal-title":"Rheumatol Int."},{"issue":"14","key":"3550_CR83","doi-asserted-by":"crossref","first-page":"e2200544119","DOI":"10.1073\/pnas.2200544119","volume":"119","author":"I Rimann","year":"2022","unstructured":"Rimann I, Gonzalez-Quintial R, Baccala R, Kiosses WB, Teijaro JR, Parker CG, Li X, Beutler B, Kono DH, Theofilopoulos AN. The solute carrier SLC15A4 is required for optimal trafficking of nucleic acid-sensing TLRs and ligands to endolysosomes. Proc Natl Acad Sci U S A. 2022;119(14):e2200544119.","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-023-03550-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-023-03550-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-023-03550-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T16:06:11Z","timestamp":1703088371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-023-03550-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["3550"],"URL":"https:\/\/doi.org\/10.1007\/s11095-023-03550-9","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"type":"print","value":"0724-8741"},{"type":"electronic","value":"1573-904X"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"10 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}